Very nice to see that EML's new chair has put down $0.52m into EML, on market, at ~$0.595 in the last 2 days.

He now holds ~0.24% of EML, up from a now minute 50k share holding prior to these purchases.

Anthony replaced Luke Bertolli in Aug 2024 and appears to be well credentialed in the payments business.

This feels like a huge tick of confidence in EML from the new Chair when EML was dredging its 52 week lows these past few weeks.

Discl: Held IRL and in SM

@thunderhead , very fair comment around the impact of interest rates on EML's interest income. Intuitively, as interest rates fall, EML's interest income should fall, negatively impacting earnings and hence negatively impacting the share price. The fall in the price post the FY24 results bothered me somewhat as I was questioning whether I had doubled down on the wrong end of the rates cycle.

To work out the correlation, I plotted each RBA rate change since EML listed in ~2013 against EML's share price. The dots are placed on the approximate date where the rate changes occured (had no space to make the dots any larger!)

Red Dots = rate DECREASES, which should negatively impact EML earnings based on the reasoning above (hence Red)

Green Dots = rate INCREASES, which should positively impact EML earnings (hence Green)

Interesting Perspective

When Rates were DECREASING in the ~2013 to ~2020 period, EML's share price was generally trending UP - it went from a ~$0.20 stock in 2013 when the Cash Rate was 2.5%, to its peak of ~$5.68 in early 2020 when the cash rate was 0.75%.

2019 to 2020 was a disaster year when all the PCSIL dramas erupted, and the price crashed to $1.25 when the Cash Rate was 0.5% - clearly, EML-specific issues drove the share price then.

CY2020 to April 2021 saw the price spike from $1.25 to $5.89, its all-time high when the cash rate was still FALLING from 0.5% 0.1%.

CY2021 to mid-CY2022 was disaster period 2 post the Sentenial Acquisition and more PCSIL dramas and the price fell to $1.25 again. The Cash Rate INCREASED from 0.1% to 2.35% in that time. Since mid-CY2022, the cash rate increased to 4.35% while the share price fell to its all time low of ~$0.40 through to current day $0.665.

So, based on the history, the impact of Covid, the big dramas around PCSIL/Sentenial, it actually appears that the EML price has actually moved broadly in the opposite direction of changes in the cash rate. The EML price has made its best gains when the rates fell, Conversely, rate increases have done very little to the price.

This is terribly counter-intuitive, I have to say. But it lines up with EML managements comment in the results call that managing interest income is BAU really, regardless of where the cash rates are.

What Does This Mean

The perceived negativity of the imminent fall in the Cash Rates in CY2025 on EML's earnings is very much in play currently, I suspect.

But the facts around the historical EML share price does not quite support that negativity. The very bullish view would be that rate cuts actually seem to play in EML's favour. The mild bullish view would be that there is no tangible evidence that rate decreases have previously depressed EML share prices.

With this rates analysis out of the way, my view is that EML is in a very good place from a turnaround perspective. The bad stuff has been decisively cremated, new management with good industry credentials are in the driving seat, there is laser focus on EML 2.0 going back to its core businesses in terms of driving revenue growth and containing costs. Further progress will take time to wash through, given cost of living pressures and business cost pressures, and patience is absolutely needed.

I topped up in late Aug at 73c, and will top up again if the price dips below say 55c.

Discl: Held IRL and in SM

With the sugar hit from high interest rates set to weigh heavily on interest income, it seems the market is taking a dim view of the quality of EML's earnings now, and into the foreseeable future. The share price has copped it quite severely since hitting its highs from earlier in the year.

Is the market missing the forest for the trees in this turnaround story?

TLDR Summary

The FY24 results, in absolute terms, were good but not great. 2HFY24 was flattish. However, the results were impressive once I layered on the very eventful events throughout FY24 as EML focused on exiting the loss making businesses, decisively addressed regulatory issues and revamped management.

Turnaround thesis remains intact. Ingredients for a successful turnaround are in place and subject to more detail at the AGM, appears directionally correct. Will need patience as management refocuses and re-invigorates the core businesses, free of distractions.

Discl: Held IRL and in SM

FY2024 RESULTS SUMMARY (All Comparisons YoY unless otherwise indicated)

Context of Results

The FY2024 results are a good reminder that EML is very much a company still in turnaround mode. FY24 has been a year where EML has been actively working to spit out the bad gum that it has been chewing AND continuing to run and grow the core EML businesses.

The parts of the businesses that has dragged EML down are now decisively gone - PCSIL, and from yesterday, Sentenial. Much of FY2024 will have been to stabilise the rest of the business while these 2 parts were cauterised.

This was a good summary of EML’s FY24.

FY2024 Results, High-Level Summary

The Core business has still been growing, although not at the historical growth rates, reflecting management distraction at the exiting of the problematic businesses. The results were certainly not too shabby, given the turnaround context:

• Total Revenue up 18% to $217.3m, Gross Debit Value up 18% to $1.46b, but this was primarily driven by a sharp 97% increase in Interest Revenue to $49.8m, with Customer Revenue growing only 6% to $167.5m 
• Interest Revenue reflects improved market rates and optimisation activities which have earned higher yields - need to understand management’s plan on how this will be sustained as the interest rate cycle shifts from rate hikes to rate cuts
• Treasury management optimisation actions have resulted in uplifting interest yield from 1.6% to 2.9%
• Underlying Gross Profit is up 19% to $166.1m, with Underlying Gross Profit sustained at ~76%
• Net Overheads are up 14%, but the historical period-by-period upward trajectory of costs in recent years have been stopped with costs in 2HFY24 falling 8% from 1HFY2024 - $5m of costs have been taken out from the 1HFY2024 cost base of $61.2m to $56.2m in 2HFY24 - management focus on cost optimisation is starting to show results. Cost take outs appear sustainable (30 roles exited, reduced ICT costs, improved debtor recoverabilities etc) - this sustainability will need to confirmed in 1HFY2025
• Underlying EBITDA including PCSIL was $57.1m - this was at the top end of market guidance of between $52m to $58m, excluding PCSIL, underlying EBITDA was $49.0m, a 19% increase
• Net Loss After Tax from continuing operations was ($9.6m), a 96% improvement. 
• PCSIL loss as a discontinued operation was ($16.9m) from ($24.5m) YoY but showed what a huge drag it was on the group

Customer revenue breakdown:

• Gifts & Incentives - flat 3% increase - some challenges with turnover of several accounts, good $4.2m, 16% growth in Corporate Incentives, but offset by continued weakness in shopping mall revenue, down $2.3m, 5%
• General Purpose Reloadable - up 7% despite growth restrictions in place for the UK business through to April 2024, underlying gross profit margin up 3% to 73%
• Digital Payments - up 12%, driven largely from Sentenial, the size of this business will shrink with the discontinued Sentenial operations in FY2025

Balance Sheet

Underlying Operating Cash Flow was $22.0m. 

Cash on hand was $43.1m, a reduction of $28.3m due to $40.8m of one-off outflows from (1) PCSIL cash usage including deconsolidation ($18.4m) (2) Net paydown of external liabilities reflecting Vendor loan note repayments and Sentenial earn out payment, net of debt drawdown ($14.4m) (3) Remediation and restructuring costs paid ($8.0m).

The net debt position is ($47.6m), but with the completion of the Sentenial sale announced on 3 Sep 2024, the net debt position will move to a net cash position of ~$5m, which significantly strengthens the balance sheet.

FY2025 Guidance

Underlying EBITDA guidance of $54m to $60m - growth of between 10% and 22% from the FY2024 Underlying EBITDA of $49m. Not too shabby at all

EML 2.0 - Building for Growth - this theme is repeated throughout the Annual Report

Extract from Chairman’s Report which best summarises the thinking and approach:

Where to From Here in FY2025

Onward and upward with EML 2.0, completely free of the baggage of PCSIL and Sentenial!

The TAM of the Prepaid market is huge and growing

And EML has a strong core, that has yet to be fully unleashed due to the severe distractions of PCSIL/Sentenial.

Key Areas to Look Out For in the EML AGM

1. Refreshed Go-to-Market Strategy for EML 2.0
2. Ambitions, Plans and Targets for growth - am expecting this to restore market excitement in what should have been EML’s growth trajectory had it not embarked on the slippery slope that was PCSIL/Sentenial.
3. How the current good momentum in Interest Revenue will be sustained in a rate cut global interest rate environment

THESIS EVALUATION

Turnaround thesis is still intact.

Since the management refresh in FY2023, EML management has laid out a clear turnaround plan and thus far, have executed against the plan - exit of PCSIL, Sentenial, cost optimisation etc. During the investor call, the new CEO described EML as “Challenge, Determination and Achievement”, a good summary of the past year and what lays ahead

Management credibility is still intact

Sensing energy in the new CEO Ron Hynes - “move at pace”, “rebuild our sales capability” and “exploit EML’s right to win” were phrases used - these feel like the right sense of urgency and priorities. Seems to have the right background and experience to lead EML 2.0. Liking the language used in his CEO’s Report

• CEO’s 6m shares LTI requires a $1.50 share price hurdle and a strike price of $1 after 2 years - good skin in the game
• The FY24 AGM will be the next major data point
• This will be a 12-18M journey at least but am prepared to be very patient and allow management to do what needs to be done

Potential Thesis Breakers

Abrupt leadership/management change - this would be a huge red flag - it has been a period of good stability since Emma Chand exited, any change to this stability would be bad news

AGM is underwhelming in terms of EML2.0 growth ambitions

An acquisition, no matter how compelling, would be another big red flag, as I can’t see management being able to handle anything new for the next 12-18 months at least - suspect the risk of this occurring is low given that the recent “troubles” are still very fresh in the mind of management and the market

Underwhelming 1HFY25 results without logical rationale would also be a red flag as it would be a sign that EML 2.0 is not quite working or gaining traction or management has lost direction/focus/energy

Position Size

Comfortable with current portfolio position size of ~2.6%.

However, current levels are very attractive to top up as downside from here is likely to be limited and the price is at the 61.8% retracement level

Will seriously consider a top up if the price drifts close to 0.60, otherwise will use the AGM as the next key data point from which to reassess the portfolio allocation.

Another milestone in EML's ongoing turnaround with the completion of the Sentenial Sale announced today:

• Sale of the Sentenial business for an enterprise value of €32.75m (A$53.4m1) has completed
• Proceeds will be used to retire debt, strengthening EML’s balance sheet
• Balance sheet will transition from net debt of $48m to net cash $5m
• Liquidity to support growth materially improves following the sale of Sentenial and establishment of new debt facilities - debt limit facility will rise to $70m
• EML will benefit further from an earnout payment from GoCardless for an amount in connection with contracts signed by Sentenial between 1 February 2024 and 2 October 2024 based on the first year’s revenue derived from those contracts, multiplied by 4.1.

There was no downward adjustment to the sale price for key contract performance - this is icing on the cake.

In the midst of digesting the FY24 earnings reports. Thesis for EML turning around is very much intact as the company has executed against the turnaround plan, with Sentenial being the last piece of the bad stuff being conclusive sold, with a little bit of earnout upside potentially. Am prepared to be patient for this turnaround to play out ...

Company is now in a much healthier position from which to go onward and upward in their core business.

Discl: Held IRL and in SM

Upto 8.62%

Appointment of Managing Director and Board Directors

• Credentials of both Ron and Anthony look good
• Retaining Kevin was flagged previously but he's earned the right to be retained with the good work he has done these past 12M
• Ron's Rem at AUD$0.8m base, with 6m shares as LTI, 2/3's vestable in 2 years assuming share price hits $1.50, with a strike price of $1, plus another $3m of service rights, vestable each year (1) looks reasonable (2) ensures good skin in the game and (3) provides an indication of where management thinks the price will be at in the short to medium term.

In the past 12-18M, Kevin has decisively cleared the stage of bad stuff. The stage is now set for Ron to perform. He sure sounds like he can put on a show. Let the real show now begin (albeit a few years later ....)!

Disl: Held IRL and in SM

This is another growth barrier lifted and EML marches towards its old operational self pre-PCSIL/Sentenial. Onward and upward, literally!

Following the close of trading on 23 April 2024 EML’s UK subsidiary Prepaid Financial Services Limited (“PFSL”) received correspondence from the Financial Conduct Authority (“FCA”) advising that following PFSL’s completion of regulatory remedial work it was satisfied that PFSL has appropriate structure and risk management controls in place and that the Voluntary Application for Imposition of Requirements (“VREQ”) preventing PFSL from entering into new customer contracts would no longer apply effective 23 April 2024.  

With immediate effect, PFSL may now onboard new customers and the team look forward to once again being an active participant in the UK payments market leveraging PFSL’s end-to-end issuance, processing and program management capabilities and UK domiciled management and operations team

The 'Wilson Stable' have accumulated EML -

The total number of votes attached to all the voting shares in the company or voting interests 6.11%

The investment Case for EML Feb 2024:

tamim_australia_all_cap_february_2024.pdf

EML Payments (ASX: EML) continued to progress with its simplification strategy and delivered a strong result benefitting from rising interest rates. Now that management has put the Irish subsidiary into liquidation, more granularity was provided to the remaining core business. Management guided to improving Ebitda margins towards 30% by FY26 through further cost cutting and new business growth. In addition the removal of the growth cap from the UK PFS subsidiary is imminent, and so is the sale of Sentenial being pursued. A new CEO will be appointed shortly and more likely will be Australian based.

We estimate the core biz will deliver $50M of Ebitda next year with strong cashflows and growing to $60M in FY26 with $30M of free cashflows.

We value the stock around $1.50 with a high likelihood of a takeover once the above catalysts are finalised. We believe a takeover of EML in time, will be closer to $2.00

EML announces that it has entered into an agreement to settle all outstanding deferred acquisition payments (“Loan Notes”) from the acquisition of Prepaid Financial Services Group (“PFS Group”) in 2020 for £15.0m (A$28.8m)

• This represents a £7.9m (A$15.2m) or ~35% reduction to the total value of the Loan Note liability if paid at face value plus interest by the specified instalment dates
• All historical earnout arrangements are confirmed at zero
• This agreement represents the conclusion of all outstanding actual and potential liabilities for EML and its shareholders flowing from the 2020 PFS Group acquisition structure. 
• Settlement of the Loan Notes concludes all outstanding matters between EML and the PFS vendors including but not limited to acquisition earnout arrangements for which nil will be paid
• The settlement amount will be paid by 31 July 2024 and funded from EML’s cash balance.
• Settlement of all outstanding actual or potential liabilities from EML’s PFS Group acquisition structure is another important milestone in the delivery of the EML Group’s strategic review. By reducing the Loan Note liability and negating all other potential liabilities arising from the PFS Group acquisition structure, inclusive of potential earnout disputes, EML will strengthen its balance sheet and further de-risk the business. 

This feels like the final nails in the PFS Group coffin, thank goodness! 

Another piece of positive news, amidst a series of positive developments in recent months, relating to both the winding up of PCSIL and the disposal of Sentenial.

I viewed the recent exit of the Alta Fox Director and the appointment of Kevin Murphy to the Board as also being another positive sign that the turnaround has reached a definitive milestone.

Topped up IRL today given the recent price pullback and on the back of this news.

Discl: Held IRL and in SM. 

Board changes at EML, with the new CEO Kevin Murphy joining as a director, and Conor Haley from Alta Fox Capital stepping down.

I guess the market is concerned about what Alta Fox will do with its stake. Hopefully they stay put to watch the turnaround complete (at a much higher share price too, fingers crossed!).

Finally had the chance to work through the EML 1HFY24 results after all the excitement with the Sentenial sale. I prefer HY-o-HY instead of PCP comparisons, so reworked some of the numbers to give me that view. It also helped that EML management is now focused on the Core business segments, so they have taken pains to focus on, and publish, H-o-H performance.

Summary of the key Group numbers, green shows growth, orange are flat to down

In summary, and the rationale for my top up of 0.25% IRL and in SM today:

1. The underlying EML business in the last 18M has been growing nicely across the key metrics, stripping out the impacts of the PCSIL and Sentenial remediation costs and isolating post-disposal impacts. This is summarised in the table below - green is growing, orange is flat to backwards.
2. Expecting EML to meet or exceed underlying EBITDA FY24 guidance - at the half year mark 53.3% of the mid point guidance has already been met.
3. Continued strong interest income revenue - interest rates likely to remain higher for longer, which is a good tailwind for EML revenue
4. Strong cash generation
5. Upside from cost remediation efforts as costs remain high and management is very focused on this.
6. Risks of another (stupid) acquisition will be remote for at least the next few years (we would hope).
7. By getting rid of PCSIL and Sentenial, EML is essentially back to being the company it was prior to the acquisition - it was a much-loved growth company. As both acquisitions were entered into when the EML price was $3.75 (PCSIL, 31 Mar 20 announcement) and $3.89 (Sentenial, 30 Sep 21 completion) (1) the core business has still been growing, and (2) we have the tailwind of high interest rates, it would appear that a re-rating to perhaps ~$3.00 is not an unthinkable scenario now.

Risks

1. Sentenial sale does not complete - low risk, it would seem
2. Another stupid acquisition - low to none, for the next few years perhaps
3. Further Board instability - low, given how the Board has stayed the course in the last year
4. New CEO - always a risk (think Emma Chand), but EML is on a much clearer and firmer trajectory now for the Board to stuff up the appointment.
5. Growth stalls due to macro factors - medium risk if Central Banks overreach and cause a major recession. an inherent risk.

At peak, my paper loss was close to 85%, and I was completely anchored to the loss. It took a lot of effort to un-anchor this negativity.

I now feel EML is back on the right path again and the growth ahead looks bright. My conviction for EML has now turned from negative to high, enough to top up 2x and bring my average cost down to a reasonable $2.31. Whether this was a right move will be revealed in the fullness of time!

Discl: Held IRL and in SM

1HFY24 Summary Slides

EML bought a Lemon - Sentenial..The fatal - on 7 April 2021. {(A$112.7 million1 ) plus an earn-out component of up to €40 million (A$64.4 million1 ). }

EML: Share price up ~ 9% this arvo

EML PAYMENTS LIMITED EML(ASX) - ASX Share Price & News | HotCopper Forum

History Below:

Microsoft Word - 011021 ASX - Completion of Sentenial v3 (Clean) (afr.com)

EML is acquiring Sentenial, including their open banking product suite, Nuapay, for an upfront enterprise value of €70 million (A$112.7 million1 ) plus an earn-out component of up to €40 million (A$64.4 million1 ). A summary of the transaction is outlined below, please also refer to our ASX announcement and presentation released on 7 April 2021.

Further notes in digesting the Sentenial sale announcement:

• Non-Core to the Group’s operations as it is unprofitable (estimated ~A$2m EBITDA loss in FY24), does not have any material product overlap with other EML Group business lines, and is separable from the Group’s wider business
• Significant milestone to the delivery of the Group’s Strategic Review
• Sale price is subject to (1) customary completion adjustments for working capital and net debt (2) potential downward price adjustment, capped at EUR7.5m linked to ongoing key contract performance in the period up to completion of sale (3) earn out based on recurring revenue from new contracts signed by the Sentenial business from 1 Feb and 30 days after Completion.
• Completion is not subject to financing
• Expected to be completed within 3 to 6 months and is subject to approval from the French and UK financial regulators

@jimmybuffalino , @thunderhead , as a long-term shareholder, I share your sentiments with the overall Sentenial debacle. I had very low expectations of a meaningful sale price, as I was more looking forward to EML minus Sentenial, so am simply esctatic at the sale, whatever the price. It just releases EML from the ongoing burden that PCSIL and Sentenial have inflicted.

I topped up in late Jan when the PSCIL wind down was announced, looking to top up again today as the Sentenial sale was an earlier defined trigger point. Hoping that with both out of the way, EML can refocus and go back to becoming the growth company it was, hopefully that much wiser about making dumb-arsed acquisitions in the future!

Discl: Held IRL and in SM.

EML has announced this morning that it has sold its Sentenial business for EUR 32.75mm, of which EUR 7.5mm is contingent upon performance of a key contract up to completion of sale. You would like to think that they are sufficiently comfortable with whatever guarantees have been given, but who knows. On balance, this is disappointing because it works out to AUD 54m (of which 4.5mm is contingent) and EML paid $172mm for the business. However, the market seems to have liked it this morning presumably because it simplifies the business and returns focus to the cash-printing operations.

Disc: held here and IRL.

I received an email from Qantas Money yesterday;

We are writing to advise you of upcoming changes to Qantas Travel Money. The below changes are effective from 27 February 2024 and are summarised as follows:  

• the Issuer will be changing from Heritage and People's Choice Limited trading as Heritage Bank (ABN 11 087 651 125, AFSL 244310) (HPC) to EML Payment Solutions Limited (ABN 30 131 436 532, AFSL 404131) (EML); 
• the Terms and Conditions for your Card will be moved to EML (called a novation). This means that your contract with HPC will end and be replaced with a contract between you and EML (New Terms and Conditions); and ... blah blah blah etc.

An additional one customer is nothing big - even though QFF as linked through Qantas Money is one of the largest rewards programs in the whole country - and it got me thinking. So I googled EML's ABN. Fascinating to see it pop up in a long list of different company websites because the ABN is listed in their T&C aka the fine print. Note to self, an interesting way of gathering data.

Further to reddogaustin’s post, Jeremy Raper’s (now unlocked) write-up for March sets the scene pretty well. His subsequent Twitter threads are also worth a read.

https://rapercapital.com/2023/03/30/new-idea-fundamental-value-w-event-kicker/

Hooray! EML are exiting its long standing problem child subsidiary in Ireland, PCSIL.

A seemingly originally rash decision to purchase (as covid started if my memory is correct) that has been an epic journey thats seen; years of ongoing augments with the Irish regulator, the booting of founding CEO Tom, and share price depreciation from ~$4 to ~$0.40!! All distracting from a good little ticket clipping payments enabler.

I'm excited for the next 12 months at EML, where value creation will improve their share price.

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02763491-2A1500267

Finally got round to working through what to do with EML after the recent AGM and price crash. Went back to the FY22 Annual Report and laid out the key numbers from FY21-FY23 in a xls to make better sense of what has happened - I find summarising this 3+ year horizon into a format which I am comfortable with from the Annual Reports provides me with significantly better picture of the commentary rather than the usual YoY or PCP basis.

Disc: Held IRL 1.06% of Portfolio

SUMMARY

• Core businesses continue to grow Gross Debit Volume and Revenue, gross margins have mostly sustained around 65%
• Continues to benefit from high interest rates for EML’s substantial stored float - this benefit will continue for the next 12-18M as interest rates stay higher for longer
• Underlying Expenses, ex-Impairment, have step increased ~26%, a good portion of that is from the Sentiniel full year contribution, impacting Profitability - management has clearly recognised the need to reign this in - cost optimisation is one of its 4 key focus areas
• Cash Flow position has improved significantly - would have been cash flow positive if not for continued compliance remediation spend
• Trading Update for 4M ending October 2023 encouraging - expect to significantly improve FY23 EBITDA by 40-56%, cash flow positive, but will continue to burn~$20m for PCSIL remediation efforts
• Management changes, other than a final CEO, appear to be stabilising, strategy has been revised and is clear, transformation effort is underway
• PCSIL continues to require significant remediation effort focus and is clearly impacting further revenue growth in Europe - Kevin Murphy the Interim CEO seems to be the right person, team to resolve has been expanded, what we now need to see is positive traction via positive Central Bank of Ireland acknowledgement

Portfolio Action

• Current holdings of EML is 1.06% of the portfolio with the average cost of $2.991, down 71.59%
• Happy to continue holding this % allocation on the back of still-robust Core businesses and the eventual resolution of the CBI issues vs exiting with NRV of ~$11k
• Not prepared to add to the holdings at the moment, but will consider this if there is tangible progress on the CBI remediation, as evidenced by formal acceptance of that improvement and/or the progressive removal of growth restrictions

CONTEXT

• Previous long-term strategy was declared flawed by new management as it (1) focused on longer-term aspirations (2) did not account for today’s business challenges which required immediate and concentrated attention (3) did not offer a clear plan to solve these challenges
• More recent acquisitions have not yielded the desired results or given rise to identifiable synergies delivering real value (1) PFS Group operates in a highly technical and evolving regulatory environment in Europe (2) Sentenial Group, slower ramp on anticipated revenues and limited synergies for EML’s open banking business
• Good progress on focus to solve the biggest business challenges today - (1) Leadership & Talent retention (2) Remediation and Regulation (3) Escalating costs and loss-making businesses (4) constrained growth

THE GOOD

• Core business strong and growing, FY23 revenue and underlying EBITDA, outperforming guidance:
• Gifting and General Purpose Reloadable Cards - Australia and UK - strong and growing Gross Debit Volumes and Revenue
• Digital Payments, including problematic Sentenial acquisition - also growing GDV and Revenue
• Gross Margins sustained at ~65%
• Cash balance $71.4m, cash flow from Operations almost at breakeven ($2.6m) vs ($41.5m FY22)
• Interest investment return, a core part of EML’s revenue mix continues to improve - $33.1m in FY23 vs $5.0m in FY22 - will continue to benefit from the global higher-for-longer interest rates forecast
• YTD Oct 2023 results and trend positive (1) Underlying EBITDA up to A$12.5m vs A$3.3m in pcp (2) Revenue is up 39% at A$26.3m, 19% growth on pcp in recurring business revenue and strong contribution from higher interest revenue and yield improvements
• FY24 guidance
• Underlying EBITDA - range of $52-$58m, an increase of 40-56% on FY23 EBITDA of $37.1m
• Cash flow broadly neutral in FY24, including PCSIL’s cash burn of ~$20m. Excluding PCSIL, EML would be significantly cash flow positive in FY24
• New leadership team is settling down after resignation of previous CEO and focused on (1) executing the Transformation Strategy (2) addressing the compliance issues (3) running the core business

THE NOT GREAT

• Declining profitability of 28% YoY
• Overhead costs are 26% higher - at least 10% across each major expense item
• Lower establishment revenue impacted by macro considerations 
• Growth restriction in PFS business in UK & Ireland offset by higher interest revenues across float holdings in Gift and GPR
• 2 very problematic acquisitions - PFS Card Services Ireland Ltd (PCSIL) and Sentenial - major regulatory compliance issues crimping operations, bleeding costs to comply and taking up a disproportionate amount of management attention - progress made but a lot of work left to do
• PCSIL cash burn in FY24 estimated to be ~$20m, elevated cash burn “likely to continue over the mid-term”
• Central Bank of Ireland not satisfied with PCSIL’s remediation plan and completion timetable
• Continued impairments of PCSIL and Sentenial businesses - $258.9m hit in FY23

PROGRESS ON OPERATIONAL PRIORITIES

• PFS business (UK and European GPR business) - made progress, now in embedding phase of remediation, added additional resources to uplift capability to resolve issues with the Central Bank of Ireland in the European business
• Cost Optimisation - simplified operating model, rationalisation of global roles to align to new strategy, identified FY24 cost savings initiatives from further simplification
• Growth in Core Business - committed investment to rebuild Sales, Marketing and Commercial teams

WHAT GOOD LOOKS LIKE

• Continued growth of core businesses while resolving compliance issues in parallel
• Completion of the execution of the Transformation Strategy
• Complete exit of PCSIL or resolve compliance issues - reduce cost burn
• Step drop in Operating Overheads as leaner organisation and cost optimisation kicks in - $10m identified thus far for FY24 execution - not big enough
• Sale of Sentenial - expressions of interest received, being reviewed but no sale forthcoming yet
• Cashflow and EBITDA positive

Noted Now Present Voting power: 12.15%

All the directors of the troubled PFS Card Services subsidiary have resigned. Not often you see that, though in this case it's likely a good thing.

Just catching up on coverage of the news flow for EML and saw there were at least three articles in todays AFR on this including:

EML ousts CEO, appoints Barrenjoey to sell ‘all or part’ of business

Activist turns EML on its head in just five months

The Chook's article probably summarises it best ...

It’s astonishing how quickly an activist investor with barely a 10 per cent stake can turn a company’s strategy, board and management team on its head.

This time last year it was Mike Cannon-Brookes’ Grok taking on AGL Energy, in a stoush that ended with a cancelled demerger, new board, new chairman and new CEO.

Grok did it with an 11.28 per cent stake, initially held in shares and derivatives.

Now it’s Texas-based Alta Fox Capital, another newcomer to the Australian activist scene, that has gone after prepaid cards business EML Payments.

Alta Fox started buying shares on November 1 last year, and built an 8.14 per cent stake across the Australian summer.

Only 168 days since that first trade, EML Payments’ board has ripped up the company’s strategy, replaced the CEO and called in the bankers to consider selling the business and/or its parts as announced on Monday morning.

The announcement was signed off by a new board put together only two months ago and including Alta Fox founder Connor Haley, an American, and former UBS banker and Afterpay CFO Luke Bortoli who is now EML Payments chairman.

The new crew also includes investment bank Barrenjoey, tasked with the strategic review.

Alta Fox track record

It’s about as wholesale as changes at a company can get, and largely sparked by Alta Fox, a small investment manager that targets underperforming companies, management teams and boards.

The situation shows it doesn’t take much to get an activist campaign going. The activists are good at picking targets, and sometimes even an 8 per cent stake is more than is needed. Once a campaign gains traction, it’s hard to stop.

Alta Fox has made a business of it. The firm has gone after US-listed toys and games maker Hasbro and digital billboards group Daktronics in the past 12 months with mixed success, and now ASX-listed EML Payments.

It fishes in small caps globally, moving quickly once buying in and often uses M&A to create value. It claims to have made about 30 per cent a year (net of fees) since inception five years ago, with its biggest winners including Swedish group Enlabs and US small-cap Collectors Universe. Both Enlabs and Collectors Universe were sold.

While it’s one thing to turn up and demand changes, it’s another to make money for shareholders. EML Payments has performed terribly for investors, with its shares down 77.8 per cent in the past year and nearly 50 per cent in the past five years.

Task No. 1 for EML’s new interim CEO Kevin Murphy, a former Bank of Ireland cards business executive, is getting on top of regulatory issues that have dogged the company for the past two years. It has underlying anti-money laundering/KYC issues, and the Central Bank of Ireland on its back.

The new board, together since February, has come in with a three-point plan for EML: strategy, leadership and focus on remediation (specifically talks with the regulator in Ireland).

The strategy has shifted to short-term in nature – resetting to focus on today’s issues, not aspirations for the long term – and should be pretty simple; offload or shutdown the trouble PFS business (the one with the regulatory issues), if possible, and allow EML and its shareholders to focus on the group’s three strong business units. The leadership change has happened.

While Murphy deals with the regulator, Barrenjoey’s bankers will try to drum up interest in the company and/or its assets. EML Payments has attracted serious interest from the likes of Bain Capital and Canada’s Nuvei Corp in the past year or two, but couldn’t agree on terms, often pushing suitors for unrealistic prices.

M&A’s expected to feature heavily in Alta Fox’s playbook at EML which for now at least seems to be in sync with chairman Bortoli and the wider board. Alta Fox sees EML as a conglomerate of payments businesses, the crown jewel of which is the gift and incentive business that’s big in Australia and offshore.

Management change

Ironically, it was M&A that turned Alta Fox off the ASX-listed payments company when it first invested a few years. Alta Fox had a small position in 2019, but sold out after EML bought Europe-based Prepaid Financial Services (Ireland) Ltd for more than $400 million.

EML popped back up on Alta Fox’s radar mid last year, when it became apparent multiple suitors were sniffing around the business. At the same time most listed fund managers had given up on the story, unable or unwilling to deal with EML’s regulatory problems.

Having started buying shares last November, Alta Fox used its still small stake to vote against resolutions at the payments’ company’s AGM on November 25. Chairman Peter Martin was not re-elected, while there was a 29 per cent vote against the remuneration report.

Alta Fox disclosed a substantial stake three days later.

EML Payments’ board has turned over since, with three new directors joining two incumbents. The next task was the company’s strategy and management, with Alta Fox concerned by the way the former board had appointed CEO Emma Shand last year, and the company’s strategy.

In the new board’s eyes, EML needed a “wartime CEO” – someone to get in the weeds, make tough decisions and deal with its regulatory issues.

It is understood EML tried to hire Murphy a few years ago – and the new brigade is confident he shouldn’t take too long to get his head around the business.

Murphy, appointed on an interim basis, was said to have “a deep understanding of the global payments industry”, “significant regulatory experience (including with the Central Bank of Ireland)” and “been involved in several successful business turnaround scenarios for private equity funds” in the board’s statement to shareholders. He’s a bit of an unknown quantity for local investors.

EML’s former long-time CEO Tom Cregan remains a significant shareholder, but is on the sidelines. He’s not connected to Alta Fox or the company’s new board.

There’re plenty of moving parts, and much talk of widespread change that could take months to play out.

Still, investors liked what they saw on Monday, pushing EML Payments shares up 13.9 per cent to 66¢. It will be a long way back to $5 plus, where the stock traded only two years ago, while it is worth remembering that activist Alta Fox’s entry price is in the 50-60¢ a share range.

DISC: (now) microscopic position held in RL and SM

I think it's worth reflecting on what the Board said of the now departing CEO when they appointed her in July last year.

Part of my readings of this was that she was expected to far better suited than the outgoing CEO Tom Cregan to deal with the Irish regulatory debacle. Now the deck chairs are being moved again. The board is responsible for overseeing risk, which the Bank of Ireland and the Sentenial Fraud stuff suggests they've failed at. The board is responsible for appointing the CEO, which they've self-evidently failed at. The board is responsible for strategy. If you look at what they were spruiking at the 2022 AGM to what they announced today I think the kindest thing you could say about their management of strategy was they were late to adapt...and that would be real kind.

I've been critical of this Board before and that remains the case. Their new operational priority includes cost optimisation. To that end I wouldn't bother putting the new CEO's name on the door as I'm not sure he's going to be there that long.

[Not held]

Price pop on a very short announcement that the Central Bank of Ireland directed that a nil% growth cap would apply to EML’s Irish subsidiary and EML confirms no change to FY23 guidance.

Full Announcement:

EML Payments Limited (ASX:EML) (“EML”), refers to its ASX announcement on 24 February 2023 and confirms that after close of trading on Thursday, 30 March 2023, the Central Bank of Ireland directed that a nil% growth cap will apply to EML’s Irish subsidiary, PFS Card Services Ireland Limited (‘PCSIL’), for the 12 months ending 31 March 2024.

EML confirms there is no change to its guidance for FY23, being Revenue of A$235m – A$245m, and underlying EBITDA of A$26m -- $34m as disclosed to the market on 22 February 2023.

EML and PCSIL remain focused on engaging constructively with the Central Bank of Ireland, working to complete the remediation program and ensuring all of the regulator’s concerns are addressed.

I am calling it quits on EML, my thesis on this stock was a simple one. A rising interest rate environemnt would give them the extra cashflow and room needed to get the regulators back onside and enable EML to become an integrated financial services company rather than a series of bolted on acquisitions. I thought Emma Shand (new CEO) and the board renewal process was key to this transistion. Emma had been in the job just under 6 months, and the board renewal had only just been completed so I was willing to give her and the board some time to turn it around. The commentary at the half was that it is a slow expensive process but is moving in the right direction @mikebrisy gives a good rundown on how the costs on professional services balloned.

Despite this, the first major cracks in my thesis started the next day after the letter from the Central Bank of Ireland was released which said they were not on track and that their remediation efforts to date were unsatisfactory. In my thesis I had expected the full change in leadership to be the first step in appeasing the Bank but this clearly is not happening. Not only were they unhappy they were also going to further restrict growth until the remediation effort was completed to their satisfaction. I did have a bit of thesis creep here and toyed with the possiblity that they would spinoff the problem acquisitions or shutdown of this part of the buisness could result in a smaller but still profitable Gift card buisness in North America, but in hindsight this was more wishful thinking than a good bet.

The 2nd and final strike for me is yesterdays sell down by Alta Fox, who only recently bought a 10% stake in the company and got a seat on the board as@Magneto and @ArrowTrades explained. For them to have aggressively bought on market, got on the board and had a good look inside the company to now want to offload their stake really can only communicate that this company is on the way out, or at best it is not going to be making them a decent return anytime soon.

So for me I am selling my EML shares, I only had a small position in RL as it was always a high risk play. The lesson I am taking from this is stay away from any comany that has major regulation issues as they suck up a lot of time and money to fix. Also dont get sucked into a company that you watched but didn't buy years ago on the implicit assumption that history would repeat. So I have sold on market this morning.

EML has today announced Connor Haley (nominated Director) fund Alta Fox Capital has sold down there position in EML.

Selling total of 7,919,513 shares at average price $0.44 ($3,484,724). Huge big red flag considering they only built a position very recently. Refer previous Straws.

Alta Fox still owns 30,434,127 shares at todays close of $0.44, its worth approx $13.4m or 8.14% shares on issue.

Start off with what we know are biggest Problems/negatives – Acquisitions been nightmare with both PFS and Sentenial both had regulatory issues. There’s been no or little effort in the remediation process with the Central Bank of Ireland. https://www.asx.com.au/asxpdf/20230224/pdf/45lzt24m6gc7l5.pdf Regulatory issues likely to impact the amount EML can grow and its compliance cost for the foreseeable future. 

Positives – What needs to happen make EML investable again!!!

First steps been taken we have a new CEO and new board. Alta Fox has recently brought in a major stake in the business and looks to have at least one seat on the board. Connor has stated publicly he’s been actively been looking for overlooked stocks that will benefit from interest rates increasing. Not sure if that’s only reason EML has appealed to Alta Fox. EML should benefit as interest rates rise due to the float it carries. Below summary of the new director’s background and current holdings. 

Current Directors

Dr Luke Bortoli (Chairman) Effective 22/02/2023 was CFO of global payments platform, Afterpay. He was with the company from 2018 to 2021 during which time the company scaled from a small-cap start-up to a globally recognised market leader. Prior to Afterpay, Dr Bortoli held various senior executive roles at Aristocrat (2015 – 2018). Effective 22/02/2023.

Peter Lang (Non-Executive Director) Effective 22/02/2023. - is a veteran payments expert, previously Group Executive at ASX-listed McMillan Shakespeare Ltd (MMS). Mr Lang was part of the management buyout team who went on to IPO MMS and deliver 30%+ CAGR during his 14-year tenure leading to the Company's admittance into the ASX200. Mr Lang’s provision of advisory services to EML in 2017 was instrumental in EML’s capture of 90%+ of the Australian salary packaging payment card market which represents a significant earnings vertical for EML today. Announced 24 Feb 23 Peter Lang will be in charge of the sub committee to oversee remediation program with CBI.

Brent Cubis (Non-Executive Director) Appointed 06/02/23 is currently the Non-Executive Director and Audit and Risk Committee Chair for A2B Australia Limited (ASX: A2B), Silverchain Group, Carbon Cybernetics, and leading youth cancer charity, Canteen Australia. His previous roles have included CFO of Cochlear Limited, CFO of Nine Network Australia and Non-Executive Director and Chair of the Audit and Risk Committee of Prime Media Group Limited. 

Manoj Kheerbat (Non-Executive Director) Appointed 05/12/22 - he brings to EML, deep insights from 20+ years’ experience working in UK and European payments ecosystems. Mr Kheerbat is European based, which reflects EML’s significant presence in Europe and the UK. He has a wealth of experience managing regulatory relationships, risk and compliance frameworks, and building structured, robust and scalable operational infrastructure to support growth. 

Emma Shand CEO effective 11/07/2022 - is a seasoned executive and multi- disciplinary leader having worked at the intersection of technology, financial services and capital markets for 25 years across Asia Pacific, the US and EMEA. She has deep experience of different operating and technology environments and diverse cultural settings in a career which includes over 16 years with US based market leader Nasdaq. 

Connor Haley (Nominee Non-Executive Director) -  is the Managing Partner of Alta Fox Capital Management, the second largest shareholder of EML. Advise Nomination 22/02/23. Haley founded Alta Fox in 2018 after working at Scopia Capital Management, a New York-based alternative asset management firm. 

No longer on Board David Liddy, Melanie Wilson, Tony Adcock

Current Market Cap $179.5m

Inside Ownership                   Ordinary Shares    % EML Issued        Net Value at $0.48      

Luke Bortoli                                         0                      0                                  0          

Peter Lang                               861,427                       0.23%                       413K    

Brent Cubis                                         0                      0                                  0

Manoj Kheerbat                                  0                      0                                  0

Emma Shand                                       0                      0                                  0          

Connor Haley (Alta Fox)          38,353,640                  10.25%                      $18.4m            

I use to hold EML shares and I have been intrigued by Alta Fox’s quick entry into EML. Currently have no plans to buy shares and I happy to watch from the sidelines for now but if  we were to see the regulatory issues finally resolved and the new board buying shares on the market, I could see room for EML in my portfolio as a turnaround special situation stock. As you can see from table above the new board holds very little or no stock at all currently. For now, it’s a watch and wait, maybe it be a takeover target, it current stock price in my opinion is very under demanding  or maybe continue to disappoint!!

Oh well, wishful thinking on my part. The Halt is due to a letter received by PFS from Central BoI. Good news or Bad, let's see.

If its bad news, it will not be a good reflection on the management and Board changes or the early days of the new strategy.

But, I am getting ahead of the facts.

Disc. Held.

$EML, which delivered its results yesterday, has paused trading pending an announcement.

Are we about to see it be taken out?

Disc: Held

·       April 2021 Sentenial Limited A$108.6m - Sentenial is a leading European Open Banking and Account-to- Account (“A2A”) payments provider, utilizing a cloud-native, API-first, full stack enterprise grade payment platform. Combining the EML & Nuapay platforms and capabilities is an opportunity to deepen customer relationships, enter new industry verticals and diversify our revenue streams. https://www.asx.com.au/asxpdf/20210407/pdf/44vb12zj1db0lv.pdf

·       March 2020 Renegotiated Terms Prepaid Financial Services Upfront A$252.3m https://www.asx.com.au/asxpdf/20200331/pdf/44gk8l3wj9lys8.pdf

·       November 2019 Prepaid Financial Services A$423 plus earn-out component of up to A$103m. PFS was founded in 2008 primarily as a reseller of pre-paid cards and has since evolved into a leading provider of white label payments and banking-as-a-service technology with a pan-European footprint. PFS provides payments and digital banking capabilities, e-wallets and payout / distribution programs, regulatory Electronic Money Institution status and flexible software to enable financial institutions and non-financial institutions alike to deliver feature-rich transactional banking and other payment services to their end-user base without becoming a regulated entity. PFS operates in 24 countries and supports over 26 currencies. https://www.asx.com.au/asxpdf/20191111/pdf/44bfybyr6bs3tz.pdf

·       May 2019 Flex-E-Card Approx. A$40.5 - is a FinTech company providing gift card solutions to the shopping mall sector, with 226 shopping centres under contract in Europe (principally the United Kingdom, Ireland, Poland, Italy, and Finland), and the United Arab Emirates. https://www.asx.com.au/asxpdf/20190520/pdf/4456ltjts3dfc3.pdf

·       July 2018 Perfect card DAC €6.0m - Ireland’s first authorised eMoney institution and a FinTech company providing incentive and corporate expense solutions. As Perfectcard is regulated by the Central Bank of Ireland, the regulator needs to approve EML as majority shareholder and we expect that approval to be forthcoming in the following months. https://www.asx.com.au/asxpdf/20180705/pdf/43w9mhn4jl6nxw.pdf

·       February 2018 Presend Prepaid Solutions (Presend Nordic AB) - SEK 10m (A$1.6m) and a two-year earn out capped at SEK 60m (A$9.5m), 100% of which is payable in shares. A leading provider of Non-Reloadable solutions for shopping malls and city/town programs in Europe, principally in the Nordic and Baltic regions. https://www.asx.com.au/asxpdf/20180207/pdf/43rdlzfkn807xj.pdf

·       May 2016 Store Financial Services, LLC US$35m - a leading provider of prepaid stored value programs in the United States of America and Canada. https://www.asx.com.au/asxpdf/20160502/pdf/436yfvm5gk3rlw.pdf

·       September 2014 Store Financial United Kingdom A$24.9 - leading provider of prepaid stored value programs in 9 European countries, including the UK. Ex Ceo Tom Cregan, was a 25% shareholder of SFUK and excluded himself from all negotiations. https://www.asx.com.au/asxpdf/20140926/pdf/42sglsymytgwyg.pdf

Alta Fox gets their set on the board. I thought they might go for 2.

Will be interesting to see how active they are

$EML reported their 1H FY23 Results this morning.

Their Highlights:

• Group Gross Debit Volume of $49.4 billion, up 55% on PCP, reflecting the benefits gained from the Sentenial acquisition

• Group Revenue of $116.6 million, up 2% on PCP, largely due to a significant increase in interest income of $7.1 million

• Underlying Gross Profit3 up 5% on PCP, driven by increased high margin revenues from Sentenial and interest

• Group Underlying EBITDA4 of $13.4 million, a decrease of 50% on PCP, largely reflecting increased underlying overheads as we continue to invest in EML’s European businesses

• Group Underlying NPATA of $0.7 million, down 95% on PCP, reflecting the same factors which reduced EBITDA

• One-off, non-cash impairments of $121.3 million against the PFS Group and the Sentenial Group

• Group net loss of ($129.9 million) largely reflecting the non-cash impairments

• Continued strength of Balance Sheet and Cash position, with cash balance up 7% to $79.2m on PCP and underlying operating cashflow conversion of 102%

• Underlying EBITDA guidance reaffirmed

• Execution of the Company’s transformation strategy, including progress with remediation activities in the UK and Ireland, streamlining the organisation and launching a new campaign in Human Capital Management 

My Takeaways

First, I acknowledge that I should have put this one down a long time ago, and it is quite close to the bottom of my conviction list. (And it is much more fun writing up results from $WTC.) All that said, these results present some evidence of stabilisation.

The impairment was inevitable, given everything that has happened over the last 2 years. Reversing that non-cash item out, statutory NPAT loss actually narrowed over the PCP.

Revenue growth was achieved thanks to higher interest rates generating interest income.

We are now seeing the full effects of the extra costs of overhead, representing all the resources that have been added to improve governance and regulatory compliance - employee expense up to $40m from $30m. Plus they are burning a steady $15m, ($30m/yr!) on professional fees, of which I assume a lot is lawyers. There is also a large bucket of $15m other expenses, which includes a variety of elements including risk and compliance. So the costs of risk and compliance appear to be spread over a number of categories and are representing a very material sum.

After everything, cash increased, thanks to the offloading of some financial assets.

These are just a few quick reflections. I'll be recording the call at 10am AEDT, as I'll be watching the Richard White concert live. I am very interested to hear what Emma Shand has to say, particularly in the Q&A. She has been on board long enough to have her arms fully around this. Whether I stay or finally go will rest on this, I expect.

Disc: Held IRL (0.75%) SM (2.9%)

Good to see that the board renewal process at EML has started - David Liddy, Melanie Wilson and Tony Adcock will resign by the next AGM. The CFO has also recently resigned. The old long serving chair got voted out at the last agm, so it will now be a completely new board and hopefully much better governance than the previous team. I wonder if the Alta fox fund is helping to get these changes through.

I am watching EML as I think the new(ish) CEO Emma Shand will do a good job of turning it around and getting the compliance problems sorted and a solid board behind her could make all the difference to the future of this company.

Update on Alta Fox position 16 Dec 22

Alta Fox have once again increased there holding in EML payments to 9.14% of shares on issue and now hold 34,177,580 shares (~$20.6 million worth stock at Fridays closing price $0.605). Increase of 3,854,311 Shares since last disclosure on 2 December 2022.

EML AGM Recording is up on their IR webiste if anyone feels like a good laugh / cry

The Chair (who was voted out at that meeting) said "A recording of the AGM will be available on our website as soon as possible after the meeting." and sure enough, after I chased it, up it went. Only took a week and a bit. Hopefully because they are all hands to the pump trying to empty their bilge faster than it keeps filling up...

Direct link is here - https://www.youtube.com/watch?v=ESmZk0vw0pk

Update on Alta Fox position

Alta Fox have increased there holding in EML payments to 8.11% of shares on issue and now hold 30,323,269 shares. Increase of 6,872,258 shares at average cost of $0.64 ($4,419.118.47).



This was also reported in an article in todays AFR:

US activist Alta Fox in EML’s henhouse, gunslinger in tow

For those without access behind the paywall...

Bombed-out EML Payments has caught the attention of a US activist investor, who’s announced its arrival with Melbourne law firm Arnold Bloch Leibler in tow

Alta Fox Capital Management, known for a crusade against Monopoly owner Hasbro in the US, only began buying EML shares on November 1 and hit 6.27 per cent on Friday, according to its initial substantial shareholding notice filed on Monday afternoon

It is understood the filing was sent to the company and the ASX by Arnold Bloch Leibler’s renowned gunslinger Jeremy Leibler, who’s never scared of a corporate stoush and has claimed more than a few scalps

While the substantial shareholder noticed only dropped on Monday, sources said Alta Fox had already been influential at EML. Its vote helped block former chairman Peter Martin’s re-election to the board on Friday. [50.49 per cent of votes cast were against his re-election]

The hedge fund should make for an interesting addition to EML Payments’ register, at a time when investors are screaming for change. EML’s largest institutional shareholder First Sentier Investors (15.58 per cent) hasn’t made much noise – at least publicly – about the 80 per cent plus share price drop this year and two foiled M&A approaches

As far as hedge funds go, Alta Fox is not a household name, especially in Australia. It owns stakes in bigger stocks like Alphabet, Amazon and KKR & Co, according to filings in the US, and several smaller US listed companies

It’s best recognised for its crusade against NASDAQ-listed Hasbro, the owner of board game Monopoly and the largest toy maker in the United States

At Hasbro, Alta Fox built a 2.5 per cent stake pushed to replace the company’s board and spin off a unit that included trading card game Magic: The Gathering and Dungeons & Dragons

Alta Fox and its founder Connor Haley were ultimately unsuccessful, but caught the attention of boards, proxy advisers and other investors

For all its willingness to start proxy fights, Alta Fox has rarely been spotted Down Under. Gunslinger Leibler’s appointment tells us it’s not here for a holiday

It’s not clear what Alta Fox’s intentions are at EML Payments. But if it’s looking to take a leaf out of its Hasbro playbook, it wouldn’t have to look too far to find kindred spirits

It has already succeeded in booting out the chair, and like-minded investors were quietly toying with the idea of selling parts of the business ahead of Friday’s annual general meeting

Announce 28/11/22 today Alta Fox Capital become a substantial holder with 23,450,011 fully paid ordinary shares giving voting power 6.27%. Alta Fox Capital is run by Connor Haley and returns of 505% since fund launch in 2018. 

Don’t hold EML IRL and recently sold due to continue concerns about regulatory issue etc.

New CEO Emma Shand. Lots of work required to rejig EML.

2924-02603362-2A1416137 (markitdigital.com)

So many red flags, but such huge upside if only a few things go right

Along with others here on SM I've done some head-scratching with EML over the last few days. I've had two waves to my EML journey. I bought shortly after the low of Covid and sold near the high when I thought it was getting overpriced. But more recently I bought back in with the sharp price drop towards end of Apr '22 when I thought it was becoming good value again, only to see it drop almost another 50%.

I've decided to stay in, and may even drip feed a little, although for the short term I'm mainly holding and watching given the momentum is clearly against the company at the moment.

Here's my reasoning, with bear and bull cases.

Bear case:

1. There has been a long string of red flags in the last 1.5 years. It started with the PFS purchase and CBI's subsequent review of governance/compliance problems in May '21, with associated restriction of trade in Europe. Then in late Apr this year we hear that EML/PFS still has unresolved compliance issues and has not yet met CBI requirements so restriction of trade will be extended. Disappointingly we had the Chairman sell $0.5m of his shares just prior to the release of bad news about the extended trade restrictions. Then the CEO resigns with no notice or good explanation. The new CEO demands an almost-$4m yearly salary, about 4x the going rate for similar sized companies. Then most recently we hear about the fraud with Senteniel, incurring up to $8m in costs (not including the costs of investigating and resolving the problem). And I'm not confident that the bad news from this latest Senteniel issues has fully surfaced - eg, if the cost to EML is up to $8m, the top line numbers that might get reported could look even scarier, and that could result in further concerns from regulatory agencies and customers. 
2. All up, there is a clear picture of poor governance and risk management.
3. Perhaps associated with all of the above issues, employee engagement score is 60% and turnover is 26%, lowest in at least the last 4 years.
4. With all of the rectification required to deal with the above problems, in their latest investor presentation EML flagged that their "overhead" expenses are likely to increase about 25% in FY23. So that's about $25m extra costs, plus up to $8m for the Senteniel fraud, plus a couple of extra million for the new expensive CEO. So at least an extra $35m in costs. They probably need to grow at least 15% just to maintain FY22 underlying EBITDA.
5. They continue to report a lot of "underlying" profit figures. I'm OK with companies using "underlying" numbers when adjusting for things like acquisition costs which are genuinely one-off. But half of EML's adjustments are for rectification costs associated with their own poor risk management. So their headline NPAT of $32m becomes a statutory loss of $5m in FY22.
6. My bear case valuation assumes sluggish top line growth resulting from recent compliance failures, growing expenses and falling margins. Assuming perhaps 5% CAGR over next 5 years, with 5% NPAT in FY27, 5% dilution along the way, with PE of 12, market cap in FY27 could be around $170m, close enough to another 50% drop from current cap.

Bull case:

1. They are a highly innovative company with lots of optionality. They have a lot of different product streams, and they only need a few to continue to thrive for them to do very well. Indeed, it's likely their governance/compliance issues are a result of their innovation outpacing their risk management processes.
2. Increasing interest rates will be a significant benefit. They provided guidance that even with the interest rate increases that have already happened, their additional revenue from interest on card stored value will be $10m+ in FY23. With further interest rate increases in FY23 this is likely to be closer to a $20m gain. And 100% of that gain goes to net margin.
3. Their new high-cost CEO is at least talking-the-talk of strong compliance and risk management. The Senteniel fraud has come to light very early in her tenure, so the fraud occurred during her predecessor's tenure (although the new CEO was on the Board at the time) , and the unearthing of the fraud may have been hastened by the new CEO's arrival and increased compliance focus.
4. Although they haven't paid dividends, they are using some of their accumulated $72m in cash for a $20m buyback in FY23, which is the equivalent of a 7% yield given the current depressed share price. It's a strong sign they see their current share prices as a strong investment.
5. My bull case valuation assumes recent compliance failures dry up. Their historical 5-year CAGR is an impressive 32%, so my bull case assumes a not-overly ambitious 15% CAGR for the next 5 years. If they can get through FY27 with 15% NPAT (which is their current underlying NPAT), undertake another round of share buybacks, and the market gives them a PE of 30 (reasonable for a highly profitable company growing 15% pa), the market cap would be $2.3b, more than 7x current cap.

The future for EML is highly uncertain and likely very volatile. I think my bear and bull cases are equally plausible. But for me, because the upside is so big (could quite possibly be a 5 bagger in the next 5 years), I'm willing to take the risk of an equally likely outcome of share price halving over next 5 years. If I assign equal probabilities to my bear and bull cases I get a valuation in 5 years of (.5 x $2.3b) + (.5 x $170m) = $1.2b which gives a risk-adjusted 30% pa return. I need a big return (eg, 20%+) to be interested in EML given their volatile history, but 30% risk-adjusted ROI is enough for me to stay interested.

My thesis assumes EML can hit the following milestones:

1. The first half of FY23 will be messy, with the ongoing PFS/CBI and Senteniel issues. But I'll be looking for green shoots in the second half, with these issues being bedded down and nothing new and overly significant cropping up.
2. Increased costs will be a strain on margins in FY23, so I'll be happy with 10% revenue growth and 5% NPAT.
3. Beyond FY23 I need to see at least 10% pa growth and 10% NPAT.

Sentenial Fraud Incident

“EML Payments Limited (ASX: EML) advises that its Sentenial business has identified recent fraudulent activity relating to an identified set of fraudulent merchants within its direct debit processing business.

EML is taking steps to investigate and understand the circumstances surrounding the fraud, and has commenced steps to recover any losses. EML is confident that the maximum amount of any losses will not exceed €5.5m (AUD7.9m) but may be lower depending on the success of recovery actions.

The fraudulent activity primarily occurred in August 2022 and came to EML’s attention on Tuesday 23 August. A meeting of the Board was convened early this morning for the purposes of informing the market.

Consistent with our ASX Listing Rule obligations, EML will update that market via the ASX platform as we have material new information.”

Disc: Still holding a small holding which seems keep getting smaller! :)

Do I understand correctly from this announcement (https://emlpayments-stagingcms.bla.bio/wp-content/uploads/2022/07/2924-02544120-2A1386360.pdf) that the new CEO will earn in FY23 $850k base + $850k STVR + $1.7m LTVR + $500k retention bonus?? Total $3.9m for a $230m revenue company, assuming she hits yet-to-be-announced performance targets. Am I misinterpreting something?

Well put by Jay Jay and road the same wave all the way up and now down.

There are simply too many questions left unanswered that simply don't fit this business being investible

On that basis i see more downside and negative news to emerge in the coming 12months.

Rough seas ahead....

No longer a holder on SM and IRL ....

My thesis is broken today. What a lesson I have learnt from this one. Once upon a time up over 250% and now down 50% in my real life portfolio.

today I have sold my entire position. Tom Cregan was a large part of my thesis which I have previously made suggesting that Since he commenced as CEO he took Eml from a issuer of shopping mall cards to a worldwide payments platform. A complex business that I feel he understood well.

what I learnt is sell when regulation issues hit a business. My second warning was the downgrade which is when I should have sold out. Funnily enough whilst reviewing my thesis of companies this weekend I said if Tom left I’d be out and come Monday it happened (weird).

I will continue to monitor the business. It has 100m on the balance sheet and is now a 400m market cap. However for now with the regulation issues I’m out and will continue to watch. The businsss will last through any downturn and I do believe it looks handsome for a takeover now.

EML Payments Announces New Managing Director and CEO

Emma Shand has been appointed Managing Director and CEO effective immediately. This follows the resignation of Mr Tom Cregan.

First things first – what has happened to Cregan? Very little detail provided about what is effectively an immediate resignation. The following is included in the announcement:

“Mr Martin said, ‘We all owe a real vote of thanks to Tom Cregan who has been an integral part of the EML growth story for over a decade. He has tirelessly led the Company from a small technology business in Australia to a diversified payments leader operating in 32 countries. EML has been an exciting growth story of rapid international expansion, not without its challenges. Without Tom’s deep payments knowledge, drive and commitment, EML would not be what it is today.’

Mr Cregan will receive his contractual entitlements and his equity will be treated in accordance with the terms of grant. No termination benefits will be provided. Ms Shand’s employment terms will be announced in due course.”

Unusual to see a CEO step down without any handover period for the new incumbent. Was Cregan forced to step aside? Has the business been notified that it will face further regulatory pressure once the current growth cap (imposed by CBI) expires, resulting in him running for the hills? A lot of questions remain following the announcement, but my gut tells me it is the former (pushed aside). This is based on some of the comments in the announcement re: how Shand will focus on the European side of the business, and how she has an ‘ideal set of attributes to lead the company into the future’. Further, ‘Ms Shand will dedicate substantive time and presence in Europe’. It seems to me like EML has assessed Cregan wasn’t best placed to take them forward.

On paper, Emma Shand appears impressive. An executive with 25 years’ global experience in tech, capital markets and financial services spanning 30 different countries (more comments about EML’s reach – presumably insinuating Emma is a better fit to lead what is increasingly becoming a global business?). Emma’s experience includes over 16 years in senior management roles with US based market leader Nasdaq. EML stress she has experience working across highly regulated markets – again further comments that maybe she is better placed to tackle the regulatory battles that EML will be faced with as it spans multiple borders, each with different legislative requirements. Given Emma has been a non-executive director at EML since September 2021, you would expect the adjustment period to be relatively smooth sailing.

That said, EML has ultimately failed to address what has caused Cregan’s departure and that will likely result in a panicked market, at least over the short term. 

Steve Mabb, chair of the ASA spoke about his correspondence with EML in 2020 on a recent episode of Shares for Beginners. EML were a new entrant to the ASX200 and weren't being monitored by the ASA at the time; however, Steve held shares and wanted to start monitoring the company.

He met with the board, dived into the annual report & worked through what they were proposing. The board had chosen to use discretion to pay out most of the management bonuses that year. This was despite not hitting their targets. The board blamed Covid saying it wasn’t in management’s control and they worked really hard. Keep in mind shareholders were down 40% by no fault of their own either.

During the AGM the chair responded that not only had they used discretion that year to pay out bonuses that because they’re in a competitive environment for staff they’ll be happy to use discretion again in the future. In other words the incentive plan isn’t hard & fast and they’ll use discretion as they see fit.

According to Steve, in the same meeting some investors challenged the company on how difficult or challenging it was to understand some of EMLs products and services. The CEO's response to those investors was that they don’t need to understand our products they just need to determine whether they trust management and if you trust management then you should invest in EML

A few months later they were in trouble around an acquisition in Ireland

The EML chat starts at 22:55

https://www.sharesforbeginners.com/blog/mabbasa

EML lowered guidance a few days ago (not by much) and got punished on top of an already negative view from the market. So, is this an over reaction or is EML in a downward spiral? I updated my valuation from a year ago for the new information and to get a view on this (detail below):

Some key insights/assumptions on the business:

·        Costs seem to be rising fast to address compliance issues and ensure they don’t happen again (above one-off PFS/CBI costs), this has lifted to underlying cost base of the business and slowed the move into profit and reduced operating leverage. I am treating most of this as a one-off step up in the cost base, so will be looking for cost control going forward.

·        Sales have also slowed due to Covid and economic conditions – no big surprise, but does impact valuation and provides some doubt for growth rates. I have modified FY22 sales to the new guidance and GDV balances to a little above double the half year results for the FY.

·        Interest rates increases provide a benefit to EML for it’s returns on the Stored Value Float (the cash held on General Purpose Reloadable cards). If a 1% increase in rates occurred globally this would add 14-15m to the bottom line based on the current 2.7bn stored float. I have added a gradual increase in interest rates to allow for this upside.

·        The large European business is at risk due to the Ukraine/Russia conflict and will be hit if it escalates, so I have upped the risk discount from 5 to 10%, still assuming only a short-term impact. I have also reduced the exit multiple down to EV/EBITDA of 12 but retained the discount rate at 10%.

·        Inflation I see as a positive tailwind for EML, the higher value of transactions and balances the higher the income for EML. The accompanying higher interest rates are also a plus as mentioned.

FY22 Guidance Adj: Apart from Operating Cashflow, only down a little – FX rate impacts and operational issue in Europe cited as key reason, but market may be concerned there is more.

·        GDV $79-$84bn (from $81-$88bn) up from $19.7bn in FY21 – mostly Sentinel addition

·        Overheads $106-$109m (from $103-112m) up from $76.8m in FY21

·        Revenue $225-235m (from $230-$250m) up from $194.2m in FY21

·        Underlying EBITDA $52-$55m (from $58-$65m) from $53.5m in FY21

·        Gross Profit Margin 69% (no change) from 67% in FY21.

·        Underlying NPATA $27-$30m (from $27-$34m)

·        Operating Cashflow 50%-60% (from 80%-90%) from 87% in FY21

EML Val.pdf

Conclusion: I have lowed my valuation from $9.71 to $6.71 with the adjustments so value has been impacted but assuming expansion and growth across the various business segments resumes and revenue can grow to 3.5x current revenue in 10 years, then it seems quite undervalued. 

Disc: I own EML

ASX Announcement - Response to Media Speculation

This morning EML responded to media speculation regarding takeover interest by Bain Capital.

EML confirmed that earlier in the year it was in discussions with Bain Capital regarding a potential change of control proposal. Those discussions have now ceased.

The Board of EML will always consider proposals presented to the company and is fully committed to acting in the best interests of, and maximising value for, EML shareholders.

EML appointed Goldman Sachs as its financial adviser and Herbert Smith Freehills as its legal adviser.

Doing some further deep dive into free cash flows EML caught my eye

On 2022 FCF it is trading 26x (rev 240m) with the forward looking numbers looking very positive on a consensus forecast.

By 2024 FCF anticipated to be 82m (rev 327m) or just under 11x.

If this bares true and valuation of free cash flow holds at 26x this places the valuation at $5.7

Nice upside potential with many growth levies at EML pathway

Transcript of an interview with Lakehouse Capital's Erwin Tan on the EML results posted on Livewire

Is this undervalued stock primed for a rebound?

Interesting chart on P36 of the EML Investor presentation. It shows the impact of rising interest rates on EBITA.

Rising interest rates significantly enhance EML’s short term profitability while at the same time reducing the long term share valuation. Interesting dynamic.

1% rise adds $14 -$15M of EBITA (by comparison H1 FY2022 EBITA $26.9M).

Also Ausbiz interview with Joe Magyer discusses EML.      

Joe weighs in on Pro Medicus, EML & Netwealth| MSL Solutions on ausbiz

Took the chance to add to my portfolio based on current discount prices.

Mixed bag of results for EML. Not sure what to think of it to be honest. I don't think it will exactly move the price much either way but I do see some light at the end of the tunnel in what has been a difficult past 2 years.

• Highlights GDP volume of 31.6 Billion up 209%
• Revenue of $114mil up 20%
• EBITDA of 26.9mil (down 4%)
• NPATA of $13.1 mil up 6%
• FY22 guidance reaffirmed between $58-65 mil

Theres a fair bit to get through in this report but some key points include

• Revenue impacted by COVID restrictions in European countries during the Christmas period with malls in Germany closed and distancing rules implemented. Positively this surely will be the last time this occurs.
• gross profit margin of 66% which were down 5% but this has been impacted by lower interest rate (which should now raise eg UK), CBI issues impacted margins but this should improve as this issue is put to bed.
• EBITDA down due to investment in to the CBI issues including general overhead costs to ensure they were meeting the requirements now and moving forward, lower net interest income and lower European set up fees. Management report they have commenced some initiatives to increase interest income, reduce scheme costs and introduce new fees on dormant balances that should improve Margins.
• Further impacted by non recurring costs in regards to CBI issue as mentioned above and also the Shine Lawyer litigation which they have set aside $10.5 mil towards their defence.
• underlying operating cash flow of 14.7 mil impacted by the delayed receipt of 2 large customers totalling $8.6mil which will come through in second half.
• the outflows are large and continue to grow but I can see that they are for future growth including acquisition costs
• EML continue to be cashed up with 86.2mil on hand as well as 30mil of contract assets (breakage accrual) with about 63% converted to cash within 12 months. Breakage accrual is essentially money from gift cards that is not spent and goes straight to EML is my understanding,

Lots of bad/avg news but positively guidance is maintained

• Revenue maintained between 230-250mil. I still expect this with the large receipts to come through to be at the top end of this guidance provided
• EBITDA maintained at $58-65 mil
• NPATA forecast between $27-34 mil.
• Pipeline remains strong in all segments and EML have a win rate of 40% which has been consistent.
• project accelerator continues to perform strongly and they have now launched a white label product named "seamless" for the US market. I am looking forward to learning more about this product in the webiner this morning.

My thoughts:

• good that they were able to maintain guidance but I am mindful of large outgoings. The report overall does not excite me. I remain bullish on the long term outlook of the company. PFS should show strong growth once CBI issue is over (which they did not confirm when this would be) and Nuapay the open banking product is signing some solid customers.
• EML will get through these difficult period and once they do I think growth will be huge, unless something else comes out of it again.
• I will not be adding to my position for now as I already have a large amount but I do believe as mentioned yesteday evening the RIsk/Reward ratio is postive.

Disc: Held IRL and SM

thought I would throw out a few predictions and expectations I am hoping for come tomorrow mornings release of results.

I am expecting the half year to be as followed in approximate figures

• GPR ~$67mil
• G&I ~$43m
• VANS ~10m
• total = ~$120mil or 26% growth
• Reaffirm guidance and I am hoping they tighten guidance to the top end of what was previously confirmed of between $240-250mil (previously 230-250 mil).

I think the figures will point towards a difficult half due to omicron variants and a not a normal European Christmas trade (think gift cards) as people were unsure about going to malls to spend but results should still be relatively strong. Remember the year prior there was pretty much no malls open. These Christmas months are EML's strongest months. Having said this I believe surely now the worst is behind and they should get some strong tailwinds with an opening environment.

I also expect management to explain strongly how a rising interest rate environment helps EML. They have mentioned this previously in historic webinars but I feel the market have not woken up to this. every 1% interest hike = 20mil for EML.

CBI update hopefully to inform us that they issue is now over. I imagine that even if it is not over they would be very close and EMLs twitter and linkedin has been very active in informing of new product launches. The cost of the issue and how much funds they need to dedicate towards this moving forward to ensure they are satisfying regulators. Once this is over I feel the company can then start focussing on what really is important.

Some other facts I want to know

1. update on open banking (I am incredibly bullish on this Nuapay acquisition and have written up about it previously (i think)
2. update on project accelerator and where Interchecks and Hydrogen are currently positioned. Interchecks is particularly interesting as they recently did another round of funding. EML initial investment of 2mil should be around $4-6mil now
3. lastly as EML saved so much money on the PFS acquisition they currently have about $150mil cash on hand. I am interested to see whether they have a plan to spend this to pursue revenue growth.

Just some thoughts. I have used recent weakness in SP to top up both in SM and IRL. I guess tomorrow I will find out whether that was dumb or not. Regardless I am bullish on the long term prospects of EML and think the risk/reward is favourable even though I acknowledge there is a lot of risk.

DISC: held

Today was a great example of how the market does not like uncertainty! As such, the EML share price has suffered accordingly. Unfortunately, at the moment the overall fundamentals are being put aside as the market assesses what the CBI request means to the future revenue generating ability of PCSIL.  

A rather vague update from EML this morning on Central Bank of Ireland (CBI) issues:

·        Potential directions from CBI are more limited than foreshadowed in May 2021.

·        However, the CBI sees PFS Card Services material growth policy as higher than they want to see.

It sounds like penalties and remediation costs are limited but controls going forward are going to limit growth rates for the Irish subsidiary.  The good news is that it’s only the PFS subsidiary, not the other entities. However there really isn’t enough detail to get excited or worried either way.

I hold EML

thesis notions.

EML is trading at around 40 times earnings, but we think that will fall as structural growth once again takes centre stage. 

Boasting a capital-light business model, sticky customers, rapid organic growth rates, $140m in cash and a share price 40% below all-time highs, we think we’re being well rewarded for the risks. We'd note the stock's 'high' risk ratings and our 3% recommended maximum weighting, but we're going with SPECULATIVE BUY. 

At 19/8/21

ASX Announcement
EML just announced that they have identified historical deficiencies relating to periods prior to EML’s acquisition with respect to the accelerated conversion into cash of funds in dormant and expired e- money accounts.

This cash would otherwise be retained in safeguarding accounts until six years post expiry of the accounts. The historical treatment is inconsistent with EML’s understanding of the correct application of the electronic money regulations.

Subject to audit, there is not expected to be an impact to EML’s profit and loss account as the issues related to the period prior to acquisition.

These deficiencies are historical in nature and pre-date the acquisition of Prepaid Financial Services Limited (‘PFS UK’) by EML on 31 March 2020. In line with our regulatory obligations, EML has proactively reported these historical issues to the Financial Conduct Authority (‘FCA’). PFS UK is an authorised eMoney Institution under UK law, its relevant regulator therefore being the FCA.

Our notification to the FCA was appreciated and we will be providing further details to the FCA next week in relation to the issues.

EML expects that the issue will require the injection of up to approximately £14.1 million (AUD 26.6 million) into safeguarded funds held by PFS UK. The injected funds may be released back to EML over an extended period, consistent with relevant regulatory requirements which allow conversion of dormant or expired eMoney. This is expected to be reflected in the FY22 to FY27 financial years.

Subject to audit, EML’s consolidated Group financial statements for the year ended 30 June 2021, will reflect the £14.1 million (AUD 26.6 million) as a liability through an adjustment to the acquisition balance sheet. As at 30 June 2021, EML’s unaudited cash balances exceed AUD 140 million. As noted above, there is not expected to be an impact to EML’s profit and loss account as the issues related to the period prior to acquisition.

EML considers that, as the issues relate wholly to the period prior to its acquisition, any and all financial consequences are the responsibility of the previous owners of the PFS group.

EML has the benefit of various warranties and indemnities under the Share Purchase Agreement entered into in March 2020 and we are assessing our position.

YTD unaudited EBITDA of $43.8, $15.7m in Q3, of that PFS has contributed around $34.4m in Gross Profit and $16m to EBITDA YTD.  PCP growth is very large, but not relevant given the impact of Covid and addition of PFS.

Regulatory Update: EML is working with CBI but it is confidential and they cannot disclose – so no news.  However, they note costs of up to $2m in FY21 are expected on legal and professional advice, with no indication at this stage on an FY22 financial impact.

They previously reiterated full year guidance except for regulatory issues, so it looks like we can knock 2m off the bottom line of the below guidance, but they look to be on track otherwise:

·         Rev 180-190m

·         EBITDA 50-54m

·         NPATA 30-33.5m

·         EBITDA per share 13.8-15.0c

If you own or are thinking of owning EML, the Ausbiz interview with the CEO is 13 minutes well spent on the Sentenial acquisition and the business in general:

Ausbiz EML CEO Tom Cregan Interview 13min

EML has just announce the acquisition of Sentenial group, for around $170m (A$110m upfront, A$60m earnout) which will add A$70b in GDV to the current A$20b but at much lower rates (around 16 basis points Vs 90 basis points for current EML business), but stronger gross margins at 90% Vs current 70%. By Fy23, assuming the full earn-out is achieved the total purchase price would be €110 million, representing a revenue multiple of less than 3 times at projected growth rates.

The Sentenial acquisition add’s two new business lines to EML, further expanding it’s offering and diversifying the business, setting it up for to be a full service international payments solution provider as open banking grows internationally. These business lines which add to the current General Purpose Reloadable (GPR), Gift & Incentive (G&I) and Virtual Account Numbers (VAN) are:

SENTENIAL: provides direct debit, credit transfers and instant payments for major European banks with annual volumes of more than €45 billion (A$70b) in Calendar Year (CY) 2020. Sentenial provides the software platform through a Software-as-a-Service (SaaS) revenue model with charges for access to the platform, as such the yield is low, at circa 1-2 basis points (bps).

NUAPAY: an Open Banking product with A2A capabilities which in CY20 processed volumes of more than €700 million. Nuapay typically provides regulated services using Payment Institution licences issued by the Financial Conduct Authority (FCA), UK and L'Autorité de contrôle prudentiel et de résolution (ACPR), France and generates higher yields of circa 10-50 bps.

I see this additional product and geographic expansion as a good deal at a good price, offering significant opportunities for EML to sell Sentenial product into markets EML is in but Sentenial isn’t and cross sell or offer a full solution to new and existing customers.  My current valuation of $9.71 will need updating, but I expect it to be a solid upward revision and the market response today of a 10% lift in price suggests the consensus is that this is a value accretive deal.

Valuation detail for EML, see report for full reasoning

EML ANNOUNCES RECORD REVENUES OF $95.3M AND EBITDA OF $28.1M

~ Group Gross Debit Volume of $10.2 billion, up 54% over PCP;

~ Group Revenue1 of $95.3 million, up 61% over PCP;

~ Group EBITDA2 of $28.1 million, up 42% over PCP;

~Group NPATA of $13.2 million, up 30% over PCP;

~ Underlying operating cash inflows of $35.1 million, up 68% on PCP; and

~ FY21 Reinstated EBITDA Guidance Range of $50.0 million - $54.0 million

Disc; I have small holding